Vima Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
300 Technology Sq Ste 8, Cambridge, Mass...Website
www.vimatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Vima Therapeutics
Vima Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for dystonia and related movement disorders. The company is advancing VIM0423, a potential first-in-class oral therapy designed to improve motor control by targeting the underlying causes of dystonia. Founded and incubated by Atlas Venture, Vima brings together a team of seasoned experts in neurology and drug development, aiming to provide effective and accessible solutions for patients affected by these challenging neurological conditionsExplore more
Vima Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vima Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vima Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Vima Therapeutics is spiking on competitors!
Click to see if Vima Therapeutics had a recent Job posting/layoffs
Vima Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Vima Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vima Therapeutics launches new products
Earning: See what the market has to say on Vima Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vima Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vima Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vima Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vima Therapeutics.
Vima Therapeutics financials insights
Gather financial insights about Vima Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$60M
Vima Therapeutics Tech Stack
A closer look at the technologies used by Vima Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Bernard Ravina, Chief Executive Officer, appeared on a podcast called "Business Of Biotech" on 11/03/2025. Topics discussed include Vima Therapeutics, Dystonia Treatment, Biotech Startup.
Events, Podcast
Funding
Funding
Vima Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vima Therapeutics
Sign Up For FreeTo access detailed company insights
Vima Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for dystonia and related movement disorders. The company is advancing VIM0423, a potential first-in-class oral therapy designed to improve motor control by targeting the underlying causes of dystonia. Founded... Read More
